Target intelligence / Profile preview

Microtubule-tubulin complex

Molecular classification
Cytoskeletal protein, Other (Tubulin dimer/polymer)
01

Overview

The **microtubule-tubulin complex** refers to the dynamic polymer formed by the assembly of α-tubulin and β-tubulin heterodimers into protofilaments, which form the cylindrical structure of microtubules, fundamental elements of the eukaryotic cytoskeleton[1][4][8]. Microtubules are essential for a broad range of cellular processes, including maintenance of cell structure, intracellular transport, cell division, and the segregation of chromosomes during mitosis and meiosis[2][7][8]. Their assembly is catalyzed by nucleating complexes like the γ-tubulin ring complex (γ-TuRC), which acts as a template to facilitate the formation of microtubules with a specific protofilament architecture[1][3][5][7]. Tubulin undergoes extensive post-translational modifications, generating a "tubulin code" that influences microtubule functions and their interactions with microtubule-associated proteins and molecular motors[4][6]. Many anticancer drugs target microtubules by stabilizing or destabilizing these polymers, leading to mitotic arrest and apoptosis of rapidly dividing cells. The microtubule-tubulin complex is thus a major therapeutic target, particularly in oncology and, to a lesser degree, in neurobiology[4][8].

Other names
MicrotubuleTubulin polymerCytoskeletal microtubuleTubulin complex
02

Mechanism of action

Inhibition of microtubule depolymerization (stabilization, e.g., paclitaxel); Inhibition of microtubule polymerization (destabilization, e.g., vincristine, colchicine); Disruption of mitotic spindle formation (cell cycle arrest); Interference with intracellular transport.

03

Biological functions

Cell divisionMaintenance of cell shapeOrganelle positioningIntracellular transportCell migrationChromosome segregationCell polarity
04

Disease associations

CancerNeurodegenerative diseaseOther (infections, developmental disorders)
05

Safety considerations

Neurotoxicity (peripheral neuropathy)Bone marrow suppressionGastrointestinal toxicityResistance mechanisms (overexpression of specific tubulin isotypes, drug efflux transporters)
06

Interacting drugs

Paclitaxel (taxol)

7 more in the full profile.

07

Biomarkers

Tubulin isotype expression (e.g., beta-III tubulin in cancer)Post-translational modifications of tubulin (acetylation, detyrosination, etc.)

Beyond the preview

Go deeper on Microtubule-tubulin complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microtubule-tubulin complex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call